LatchBio
LatchBio is a San Francisco-based biotech software company that provides a cloud-based, code-free bioinformatics platform for analyzing biological data, serving 300+ biopharma and R&D labs and 40+ kit/instrument solution providers with usage-based pricing and AI-assisted workflows.
- Company typePrivate
- Founded2021
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What LatchBio does
LatchBio is a San Francisco-based biotechnology software company founded in 2021 that provides a cloud-based, code-free platform for bioinformatics data analysis. Its core product combines five modules — Workflows (Nextflow/Snakemake/Python SDK orchestration), Pods (scalable compute), Plots (interactive visualizations), Registry (experimental metadata), and centralized File Storage — with a library of verified pre-built pipelines for assays such as Bulk RNA-seq, scRNA-seq, AlphaFold, CRISPResso2, CAS-OFFinder, CRISPOR, and MAGeCK. An AI Agent powered by Claude 4.5 Opus adds natural-language cell-type identification across multimodal data formats.
The platform serves two primary customer segments: (1) biopharma and R&D labs (300+ including Amgen, GSK, Takeda, Broad Institute, AstraZeneca, Arc Institute, Elsie Biotechnologies) requiring IND-ready, SOC 2 Type II and 21 CFR Part 11 compliant analysis for drug discovery and regulated workflows, and (2) solution providers — NGS kit and instrument manufacturers such as Illumina, SeqWell, Fluent BioSciences, HaspBio, and Curio — who deploy white-labeled customer portals on LatchBio's infrastructure to attach downstream analysis to their reagents and accelerate kit repurchases. The company claims 72% cost savings versus AWS, GCP, and Azure and an 80% reduction in per-run RNA-seq cost ($2,000 to $150), validated by named customer testimonials.
LatchBio monetizes through usage-based pricing on cloud compute and storage (no seat or licensing fees) supplemented by professional services for integration, onboarding, and training, with an enterprise direct-sales motion layered on top of self-serve PLG acquisition. Distribution is global via a web console (console.latch.bio), white-labeled OEM portals, and Python API endpoints. Capital structure is private, venture-backed, with a $28 million Series A led by Coatue and Lux Capital in June 2022 and no subsequently announced funding round in the source data.
LatchBio firmographics
Firmographics- Name
- LatchBio
- Legal name
- LatchBio, Inc.
- Website
- https://latch.bio
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LatchBio is a San Francisco-based biotech software company that provides a cloud-based, code-free bioinformatics platform for analyzing biological data, serving 300+ biopharma and R&D labs and 40+ kit/instrument solution providers with usage-based pricing and AI-assisted workflows.
- Ownership category
- akta.pro rank
LatchBio industry classification
Industry- Product category
- Cloud Bioinformatics Software
- NAICS
- Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
Keywords
Where LatchBio is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
LatchBio business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations
Revenue model
- Cloud Platform Access: Usage-based pricing model for accessing the LatchBio cloud platform for biological data analysis. Users pay only for compute and storage resources consumed.
- Professional Services: Integration, onboarding, training, and other professional services for enterprise customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | Usage-based pricing with no seat/licensing costs |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
LatchBio product offering
Product offeringCore offering
LatchBio provides a modular, code-free cloud-based bioinformatics data analysis platform that enables biological researchers to process and interpret data from over 40 NGS kits and instruments without coding or cloud infrastructure expertise. The platform combines serverless workflow orchestration, scalable compute pods, interactive visualizations, and an AI Agent for biology to deliver reproducible, IND-ready analyses for biopharma R&D teams, and offers white-labeled analysis portals for NGS solution providers.
Product overview
LatchBio is a modular cloud-based data platform for biological research analysis, featuring a platform-plus-modules architecture. The core platform consists of Plots (interactive visualizations), Pods (scalable compute instances), Workflows (orchestration with Nextflow/Snakemake/Python SDK), Registry (metadata management), and File Storage (centralized data management). The platform offers pre-built Verified Workflows for common bioinformatics assays including Bulk RNA-Seq, AlphaFold, CRISPResso2, CAS-OFFinder, CRISPOR, and MAGeCK, along with specialized solutions for Spatial Transcriptomics, Gene Editing, qPCR, and ATAC-Seq. An AI Agent powered by Claude 4.5 Opus enables natural language interaction with biological data. The platform serves 40+ solution providers and 300+ biopharmas and R&D labs, supporting 40+ kits and instruments with usage-based pricing offering over 72% cost savings versus AWS, GCP, and Azure.
Differentiator
Problem solved
Functional benefit
Products and services
- LatchBio Cloud Platform Cloud-based bioinformatics platform enabling bench scientists, computational biologists, and R&D teams to analyze data from 40+ supported kits and instruments without coding or cloud infrastructure expertise. Used by 4,000+ scientists and 300+ biopharmas and R&D labs.
- Solution Providers White-Label Portal Customizable, white-labeled analysis portal offered to NGS kit providers, instrument manufacturers, and assay developers so they can deliver branded data analysis to their customers. Deployable in under four weeks with no extra cost per customer.
- AI Agent for Biology Data Analysis AI-powered agent embedded in the LatchBio platform that identifies cell types in single-cell and spatial biology datasets and processes multimodal biological data files, enabling natural-language interaction with biological data.
- Latch Developer SDKs (Python, Nextflow, Snakemake) Developer toolchain comprising the open-source Python SDK, the Nextflow SDK, and the Snakemake SDK, allowing bioinformaticians to define serverless workflows in plain Python, Nextflow, or Snakemake and deploy corresponding no-code interfaces on LatchBio's managed cloud infrastructure.
- Verified Bioinformatics Workflows Pre-built, optimized workflows for common assays including Bulk RNA-seq (alignment and differential expression), scRNA-seq, AlphaFold protein structure prediction, ColabFold, CRISPResso2, CAS-OFFinder, CRISPOR, and the MAGeCK CRISPR screen suite, runnable on the LatchBio cloud platform.
Quantifiable outcome
- 80% cost reduction for RNA-seq data analysis ($2,000 to $150 per run)
- +2 more outcomes
Companies that use LatchBio
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
LatchBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature11 records
LatchBio partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Scantox GroupcoreLatchBio migrated Scantox's DuplexSeq error-corrected sequencing technology to a scalable cloud-based bioinformatics platform. Migration restores customer access to mutagenesis assays with reagent kits available immediately and expanded commercial availability expected Q3 2026.
- Fulcrum GenomicscoreSupported the technical migration of DuplexSeq bioinformatics to LatchBio's cloud platform. Clint Valentine, original pipeline architect, led the migration confirming equivalent outputs to the original TwinStrand pipeline.
- Takara BiocoreJoint webinar partnership on spatial analysis of Seeker and Trekker Datasets. Takara Bio's instruments supported on the LatchBio platform.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
LatchBio competitors and assessment
Company assessmentDirect peers
- DNAnexus: Cloud-based genomics and biomedical data analysis platform serving pharma, clinical labs, and consortia. Directly comparable as a managed bioinformatics workflow platform with enterprise-grade compliance, similar to LatchBio's positioning.
- Velsera (formerly Seven Bridges Genomics): Biomedical informatics platform offering cloud-based workflows for genomics, multi-omics, and clinical analysis. Directly overlaps LatchBio in bioinformatics-as-a-service for pharma and clinical research customers.
- Geneyx: Genomics data analysis and interpretation platform serving clinical and research labs. Comparable as a specialized bioinformatics analysis platform with clinical-grade capabilities and a similar target customer base.
- BC Platforms: Genomics and clinical data management platform used by pharma, biobanks, and research networks. Directly comparable in offering cloud-based bioinformatics data analysis to regulated life science customers.
Broad incumbents
- Benchling: Broader life science R&D cloud platform with expanding bioinformatics and omics capabilities. Larger, well-funded incumbent that competes for the same biopharma R&D budget with a wider product suite that now encroaches on LatchBio's sequencing analysis territory.
- AWS HealthOmics: Hyperscaler bioinformatics service offering managed genomics and multi-omics pipelines on AWS infrastructure. Competes on the same cloud-bioinformatics workload with deep cloud-native integration that LatchBio must position against on cost and ease-of-use.
- Google Cloud Life Sciences: Google's cloud-based platform for processing genomics and biomedical data at scale. Overlaps with LatchBio's cloud workflow orchestration and benefits from underlying GCP integration similar to how LatchBio competes on cost versus GCP.
- Illumina Connected Analytics: Illumina's cloud informatics suite for sequencing data management and analysis. A sequencing-instrument vendor's embedded platform, comparable to LatchBio's white-label model serving Illumina and other kit providers.
Emerging players
- Element Biosciences: Sequencing instrument vendor with growing cloud informatics capabilities. Represents the emerging category of instrument makers bundling analysis software, which competes with LatchBio's solution-provider model.
Others
- nf-core: Community-curated set of best-practice Nextflow bioinformatics pipelines. The dominant open-source alternative that LatchBio packages and operationalizes, representing the free substitute that caps LatchBio's pricing power.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
LatchBio social profiles
Digital presenceLatchBio compliance and trust
Trust signalCompliance2 records
LatchBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
LatchBio leadership team
Management profileNumber of profiles
Profiles4 records
LatchBio funding detail
Funding detailFunding overview
Funding rounds4 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LatchBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LatchBio
What does LatchBio do?
LatchBio provides a modular, code-free cloud-based bioinformatics data analysis platform that enables biological researchers to process and interpret data from over 40 NGS kits and instruments without coding or cloud infrastructure expertise. The platform combines serverless workflow orchestration, scalable compute pods, interactive visualizations, and an AI Agent for biology to deliver reproducible, IND-ready analyses for biopharma R&D teams, and offers white-labeled analysis portals for NGS solution providers.
Is LatchBio a public or private company?
LatchBio is a private company. It is classified as venture growth investor backed and is currently operating.
When was LatchBio founded?
LatchBio was founded in 2021. It employs 11 to 50 people.
Where is LatchBio based?
LatchBio is headquartered in San Francisco, United States, in the North America region.
How does LatchBio make money?
Two revenue lines are on record. Cloud Platform Access are the primary driver. The others are professional Services.
Who are LatchBio's main competitors?
Direct peers on record are DNAnexus, Velsera (formerly Seven Bridges Genomics), Geneyx and BC Platforms. Broad incumbents are Benchling, AWS HealthOmics, Google Cloud Life Sciences and Illumina Connected Analytics. Element Biosciences is listed as an emerging player. nf-core is listed as an others.
Does LatchBio have an API?
Yes. The Latch SDK provides programmatic API endpoints for running workflows. Developers can define computational workflows in Python, package them into Docker images, and run them on LatchBio's managed cloud infrastructure. The SDK offers programmatic execution capabilities including programmatic API endpoints for running workflows, single line definition of arbitrary resource requirements (CPU, GPU) for serverless execution, and programmatic batch execution via CSV parameter import. The Python SDK also supports conditional sections (if-elif-else logic), task parallelization via map_task, caching and version control. Developer documentation is at docs.latch.bio.
What industry is LatchBio in?
LatchBio's product category is Cloud Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5132 and its SIC code is 7372.